Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
23,349,748
-
Share change
-
-143,964
-
Total reported value
-
$3,935,669,170
-
Put/Call ratio
-
154%
-
Price per share
-
$168.57
-
Number of holders
-
315
-
Value change
-
+$16,669,767
-
Number of buys
-
149
-
Number of sells
-
121
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q1 2019
As of 31 Mar 2019,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
315 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,349,748 shares.
The largest 10 holders included
Capital Research Global Investors, Capital World Investors, FRANKLIN RESOURCES INC, CANADA PENSION PLAN INVESTMENT BOARD, PRUDENTIAL PLC, SCOPIA CAPITAL MANAGEMENT LP, Rock Springs Capital Management LP, LORD, ABBETT & CO. LLC, JANUS HENDERSON GROUP PLC, and CITADEL ADVISORS LLC.
This page lists
315
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.